Abstract
We report the case of a newborn infant affected by congenital hyperinsulinism who developed cholelithiasis associated with cholestatic jaundice following treatment with octreotide, a somatostatin analogue.
MeSH terms
-
Cholelithiasis / chemically induced*
-
Cholelithiasis / diagnostic imaging
-
Female
-
Humans
-
Hypoglycemia / drug therapy*
-
Infant, Newborn
-
Infant, Premature, Diseases / drug therapy*
-
Octreotide / administration & dosage
-
Octreotide / adverse effects*
-
Ultrasonography